OKYO Pharma Ltd ADR
Quarterly Financials
| Values in thousands | 2026-06-30 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|
Gross Profit | -1 | ||
EBITDA | -6,405 | -2,792 | -3,751 |
EBIT | -6,406 | -2,793 | -3,752 |
Net Income | -6,362 | -2,586 | -2,026 |
Free Cash Flow | -4,413 | -1,528 | -1,570 |
Cash | 14,594 | 4,220 | 1,560 |
Basic Shares | 37,389 | 37,421 | 36,020 |
Annual Financials
| Values in thousands | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2 | -3 | -6,749 | |
EBITDA | -8,465 | -7,083 | -15,745 | -13,083 |
EBIT | -8,467 | -7,086 | -15,749 | -13,087 |
Net Income | -8,949 | -4,706 | -16,825 | -13,272 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -5,941 | -1,812 | -9,490 | -7,701 |
Cash | 14,594 | 1,560 | 826 | 4,045 |
Basic Shares | 37,357 | 39,488 | 29,343 | 22,257 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-06-30 | -$0.06 |
2024-12-31 | -$0.08 |
2024-06-30 | -$0.09 |